For founders, investors and acquirers operating in European HealthTech, understanding this new shape of the market matters more than tracking any single quarterly funding figure. The headline numbers now tell contradictory stories depending on which slice you examine, European digital health funding in the first quarter of 2026 fell 44% year on year, yet first-half funding rose 60% over the same period. Both figures are accurate. Reconciling them is the key to understanding w

The adoption and integration of digital health technologies (DHTs), including digital therapeutics (DTx), remote patient monitoring (RPM) platforms, and artificial intelligence (AI)-driven diagnostics, across European healthcare systems present a fragmented landscape. While market access for traditional medical devices in the European Union relies on unified regulatory standards under the European Medical Devices Regulation (MDR), the pathways governing Health Technology Asse

The European digital health and healthcare technology (HealthTech) landscape is undergoing a profound structural transformation, transitioning from an era of speculative, growth-at-all-costs capital deployment to a disciplined, metric-driven environment focused on unit economics, clinical utility, and artificial intelligence integration. While global bulge-bracket institutions continue to dominate mega-cap transactions, a highly specialised tier of boutique investment banks h

The European healthcare technology and medical technology sectors have reached a definitive inflection point in 2026, transitioning from a period of venture-subsidised experimentation to an era of disciplined industrial maturity. This shift is characterized by a "Great Rationalization," where the market has moved past the speculative exuberance of the early 2020s and settled into a rigorous "flight to quality". Central to this transformation is the emergence of the "Founder B

Nelson Advisors LLP, a UK-based firm, is explicitly and exclusively focused on providing mergers and acquisitions (M&A) advisory services within the healthcare technology sector across the United Kingdom, Europe, and North America. The firm’s core value proposition is rooted in a distinctive "practitioner-led" approach. This model is a direct function of the synergistic partnership between its two co-founders, whose professional backgrounds combine extensive corporate finance